Bioventix (LON:BVXP)
1,690p+0.90%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Tau pipeline offers Alzheimer’s hope; core royalties fund 9% yield despite maturing markets and currency headwinds.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxy…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £95.4M
Recent dividends
- 9 Apr 202670.00p
- 6 Nov 202580.00p
- 10 Apr 202570.00p
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Bioventix and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free